维普中文期刊产品整合服务
5篇 您的检索式:作者名="Anant Gupta"
    题名 作者 年代 出处 被引量
1Aggressive Approach to Staghorn Calculi—Safety and Efficacy of Multiple Tracts Percutaneous Nephrolithotomy显示文摘Manish Singla Aneesh Srivastava Rakesh Kapoor Nitin Gupta Mohd S. Ansari Deepak Dubey Anant Kumar 2008Urology2008,,6:2
2High-Current-Density Electron Emission from Lead Zirconium Titanate Ferroelectric Disc under Application of Short-Duration High-Voltage Pulses显示文摘Anand Moorti Prasad Anant Naik Parshotam Dass Gupta 2004IEEE Trans Plasma Sci2004,32,1:1
3显示文摘Anand Moorti Prasad Anant Naik Parshotam Dass Gupta 2004IEEE Transactions on Plasma Science2004,32,1:1
4Prevalence of celiac disease in nutritional anemia at a tertiary care center显示文摘Amit Kavimandan Meenakshi Sharma Anil K. Verma Prasenjit Das Prabhash Mishra Sanjeev Sinha Anant Mohan V. Sreenivas Siddhartha Datta Gupta Govind K. Makharia 2014Indian Journal of Gastroenterology2014,,2:1
5Current status and future challenges with Coronavirus(COVID-19):an update on vaccines显示文摘SARS-COV-2 coronavirus causes COVID-19,which is a respiratory disease.COVID-19,the common cold,seasonal allergies,and the flu have many similar symptoms.COVID-19 is caused by SARS-CoV-2,while rhinoviruses most often cause the common cold.The World Health Organization issued notifications on December 30,2019,and January 30,2020,classifying this viral disease as a Public Health Emergency of International Concern.SARS-CoV-2 was detected in humans and animals in 2019.Several investigations are underway to cure COVID-19 and develop a vaccine to prevent infection with SARS-CoV-2.Several COVID-19 vaccines have now been approved or licensed for human use(SII/Covishield,AstraZeneca/AZD1222,Janssen/Ad26.COV 2.S,Sinopharm,Moderna,Sinovac-CoronaVac,Covaxin).Four issues arise in the research and manufacture of the COVID-19 vaccine:production,affordability,allocation and deployment.The adenovirus-vectored and mRNA-based vaccines for COVID-19 showed the highest efficacy after the first and second doses,respectively.The mRNA-based vaccines had higher side effects.Remarkably few experienced extreme adverse effects and all stimulated robust immune responses.Kumar Rakesh Shriya Gupta Anant Gupta 2023Life Research2023,6,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费